Salivary gland type cancer of the breast

ORPHA:213557DiseaseAdult

Эпидемиология23

Тип оценки	Класс распространённости	Среднее (на 100к)	Регион	Квалификация
Annual incidence	<1 / 1 000 000	0.05	Europe	Value and class
Annual incidence	<1 / 1 000 000	0.038	Austria	Value and class
Annual incidence	<1 / 1 000 000	0.095	Belgium	Value and class
Annual incidence	<1 / 1 000 000	0.024	Bulgaria	Value and class
Annual incidence	<1 / 1 000 000	0.014	Croatia	Value and class
Annual incidence	<1 / 1 000 000	0.068	Czech Republic	Value and class
Annual incidence	<1 / 1 000 000	0.024	Finland	Value and class
Annual incidence	<1 / 1 000 000	0.077	Germany	Value and class
Annual incidence	<1 / 1 000 000	0.037	Ireland	Value and class
Annual incidence	<1 / 1 000 000	0.075	Italy	Value and class
Annual incidence	<1 / 1 000 000	0.043	Latvia	Value and class
Annual incidence	<1 / 1 000 000	0.017	Lithuania	Value and class
Annual incidence	<1 / 1 000 000	0.031	Malta	Value and class
Annual incidence	<1 / 1 000 000	0.06	Norway	Value and class
Annual incidence	<1 / 1 000 000	0.013	Poland	Value and class
Annual incidence	<1 / 1 000 000	0.039	Portugal	Value and class
Annual incidence	<1 / 1 000 000	0.019	Slovakia	Value and class
Annual incidence	<1 / 1 000 000	0.044	Slovenia	Value and class
Annual incidence	<1 / 1 000 000	0.054	Spain	Value and class
Annual incidence	<1 / 1 000 000	0.09	Switzerland	Value and class
Annual incidence	<1 / 1 000 000	0.064	Netherlands	Value and class
Annual incidence	<1 / 1 000 000	0.053	United Kingdom	Value and class
Annual incidence	1-9 / 1 000 000	0.323	Estonia	Value and class

Источник: Open Targets Platform (в реальном времени)

Источник: ClinicalTrials.gov (в реальном времени)